The global Pets NSAIDs market size is predicted to grow from US$ 484 million in 2025 to US$ 691 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.

Veterinary nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to control fever, pain, and other signs of inflammation in animals. Inflammation is the bodys response to irritation or injury and results in redness, warmth, swelling, and pain in the inflamed area.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 43%.

Infinity Market Research newest research report, the Pets NSAIDs Industry Forecast looks at past sales and reviews total world Pets NSAIDs sales in 2024, providing a comprehensive analysis by region and market sector of projected Pets NSAIDs sales for 2025 through 2031. With Pets NSAIDs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pets NSAIDs industry.

This Insight Report provides a comprehensive analysis of the global Pets NSAIDs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pets NSAIDs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Pets NSAIDs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pets NSAIDs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pets NSAIDs.

This report presents a comprehensive overview, market shares, and growth opportunities of Pets NSAIDs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Injection Type
    Oral Type
    Others

Segmentation by Application:

    Pet Hospital
    Pet Shop
    Household Use

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Merck
    Bayer
    JandJ
    GSK
    Septodont
    Roche
    PerioChip
    Mobic
    Rimadyl
    Vetprofen
    Novox

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pets NSAIDs market?
What factors are driving Pets NSAIDs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pets NSAIDs market opportunities vary by end market size?
How does Pets NSAIDs break out by Type, by Application?